{"id":"NCT01392469","sponsor":"Novartis Pharmaceuticals","briefTitle":"Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants","officialTitle":"A Non-Randomized, Multiple Dose, Three Treatment Period, Open-Label, Single Sequence, Single Group Study to Evaluate the Pharmacokinetic Effect of Two Doses of QTI571 (Imatinib) on the Co-administered Drugs Sildenafil and Bosentan in Pulmonary Arterial Hypertension (PAH) Patients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-04-20","primaryCompletion":"2012-10-25","completion":"2012-10-25","firstPosted":"2011-07-12","resultsPosted":"2021-06-21","lastUpdate":"2021-06-21"},"enrollment":21,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Pulmonary Arterial Hypertension"],"interventions":[{"type":"DRUG","name":"Imatinib","otherNames":["QTI571"]},{"type":"DRUG","name":"Sildenafil","otherNames":[]},{"type":"DRUG","name":"Bosentan","otherNames":[]}],"arms":[{"label":"Imatinib + Bosentan + Sildenafil","type":"EXPERIMENTAL"}],"summary":"The purpose of this study was to investigate the effects of QTI571 (imatinib) on pharmacokinetics of bosentan and sildenafil at steady state when co-administered to participants with pulmonary arterial hypertension.","primaryOutcome":{"measure":"Geometric Mean Ratio of Dose Normalized Area Under the Curve From Time Zero to Tau (AUCtau) for Bosentan Before and After Imatinib Administrations","timeFrame":"Day 1: pre-dose, Day 8: pre-dose, 0.5, 1, 2, 3, 4, 6, 8, 10 and 12 hours post-dose, Day 9: pre-dose, Days 22 and 36: pre-dose, 0.5, 1, 2, 3, 4, 6, 8, 10, 12 and 24 hours post-dose","effectByArm":[{"arm":"Bosentan + Sildenafil (Reference)","deltaMin":93.3,"sd":49.9},{"arm":"Imatinib (200 mg/Day) + Bosentan + Sildenafil (Test 1)","deltaMin":109,"sd":52},{"arm":"Imatinib (400 mg/Day) + Bosentan + Sildenafil (Test 2)","deltaMin":131,"sd":38}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG002","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":4},"locations":{"siteCount":11,"countries":["United States","Australia","Belgium","Germany","Italy","Lithuania","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":21},"commonTop":["Diarrhoea","Nausea","Oedema peripheral","Vomiting","Anaemia"]}}